Similar articles

• Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".

  Koesters M, Becker T, Weinmann S. Koesters M, et al. Biol Psychiatry. 2009 Sep 1;66(5):e7; authour reply e9-10. doi: 10.1016/j.biopsych.2009.01.035. Epub 2009 Jun 11. Biol Psychiatry. 2009. PMID: 19520365 No abstract available.
• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

  Thase ME, Entsuah AR, Rudolph RL. Thase ME, et al. Br J Psychiatry. 2001 Mar;178:234-41. doi: 10.1192/bjp.178.3.234. Br J Psychiatry. 2001. PMID: 11230034
• Venlafaxine versus sertraline for major depressive disorder.

  Wise TN, Sheridan MJ. Wise TN, et al. J Clin Psychiatry. 2000 Nov;61(11):873-4. doi: 10.4088/jcp.v61n1111c. J Clin Psychiatry. 2000. PMID: 11105744 No abstract available.
• Venlafaxine: a 2003 update.

  Gutierrez MA, Stimmel GL, Aiso JY. Gutierrez MA, et al. Clin Ther. 2003 Aug;25(8):2138-54. doi: 10.1016/s0149-2918(03)80210-2. Clin Ther. 2003. PMID: 14512125 Review.
• Antidepressant options: venlafaxine in perspective.

  Thase ME. Thase ME. J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):10S-18S; discussion 18S-20S. doi: 10.1097/00004714-199606002-00003. J Clin Psychopharmacol. 1996. PMID: 8784644 Review.